Counterfeiting, Compliance, and Controls

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2003, Volume 27, Issue 9

FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.

Related Content:

Regulatory WatchSupply ChainAnticounterfeiting, Track and Trace SystemsPharmaceutical Technology-09-02-2003
Opening Up Opportunities in 2023
A Rocky Road Ahead for FDA and Industry